Company Information

  

Address: 5421 AVENIDA ENCINAS
SUITE F 
City: San Diego 
State: CA 
Zip Code: 92008 
Telephone: 858-480-2400 

Description of Business

Primary SIC Code: 3841
(As filed with the SEC)  

We are a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss. Our initial product offering is the Obalon balloon system, the first swallowable, gas-filled intragastric balloon designed to provide progressive and sustained weight loss in obese patients. We recently received premarket approval, or PMA, from the U.S. Food and Drug Administration, or FDA, to market our balloon system for temporary use to facilitate weight loss in obese adults with a body mass index, or BMI, of 30 to 40, who have failed to lose weight through diet and exercise. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/20177.59NA1.31
03/20170.90NA11.88
12/2016-4.85NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.15Total Liab/Total Assets0.18
Net Inc/Total Assets-0.26Total Liab/Inv Cap0.20
Net Inc/Inv Cap-0.28Total Liab/Comm Equity0.10
Pretax Inc/Net Sales-6.03Interest Coverage Ratio-41.91
Net Inc/Net Sales-6.03Curr Debt/EquityNA
Cash Flow/Net Sales-5.71LTD/Equity0.15
SG&A/NetSales3.01Total Debt/Equity0.15
Asset Utilization   Liquidity  
Net Receivables Turnover5.90Quick Ratio16.82
Inventory Turnover4.72Current Ratio17.00
Inventory Day Sales0.01Net Rec/Curr Assets0.01
Net Sales/Work Cap0.05Inv/Curr Assets0.01
Net Sales/PP&E4.73  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 1.96 1.47 0.77 0.77
Cost of Goods Sold 0.99 0.82 0.87 0.64
Selling & Admin Exps 5.85 5.94 4.83 2.41
Operating Income -7.64 -7.69 -7.53 -4.45
Interest Exp 0.04 0.05 0.05 0.14
Pretax Income -7.73 -7.75 -7.50 -5.26
Other Income -0.06 0.00 0.09 -0.67
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -7.73 -7.75 -7.50 -5.26

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 60.73 66.72 75.48 14.15
Receivables - Total 1.76 1.04 0.52 0.52
Inventories - Total 0.75 0.93 0.83 0.44
Total Current Assets 63.93 69.69 78.06 17.96
Net Property, Plant & Equipment 1.04 0.90 0.72 0.54
Total Assets 64.98 70.59 78.78 18.50
Liabilities        
Accounts Payable 3.27 2.50 3.19 1.89
Debt in Current Liabilities NA NA 0.00 0.00
Total Current Liabilities 4.82 3.63 4.59 5.21
Long-Term Debt 9.90 9.89 9.88 9.89
Total Liabilities 14.76 13.52 14.47 15.09
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock NA NA NA NA
Common Stock 0.02 0.02 0.02 0.00
Retained Earnings -92.08 -84.35 -76.61 -69.11
Treasury Stock NA NA NA NA
Total Stockholders' Equity 50.22 57.07 64.31 -67.09
Total Liabilities and Stockholders' Equity 64.98 70.59 78.78 -52.00

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -6.06 -8.35 -5.78 -4.93
Net Cash Provided by Investing Activities -30.08 -22.91 9.21 1.89
Net Cash Provided by Financing Activities 0.25 0.00 67.22 1.04

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/20143.54-9.89--
12/20154.04-15.56--
12/20163.39-20.47-4.85
Growth Rates-2.08----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17657,71345.85




Report Date : 10/23/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.